Retrospective study results on patients undergoing sacroiliac (SI) joint fusion or fixation showed a 5.7% revision rate in fusion patients receiving SI-BONE’s iFuse™ vs. a 30.8% revision rate for those undergoing screw fixation.
Specifically, four-year cumulative revision rates showed a 5.7% revision rate for 263 patients receiving the triangular iFuse implant vs. a 30.8% revision rate for 36 patients who underwent SI joint screw fixation. At the longest follow-up, the cumulative probability of revision in the screw group was 79.8%. Subgroup analysis showed no predictors of revision other than device used (iFuse vs. screw).
Retrospective study results on patients undergoing sacroiliac (SI) joint fusion or fixation showed a 5.7% revision rate in fusion patients receiving SI-BONE's iFuse™ vs. a 30.8% revision rate for those undergoing screw fixation.
Specifically, four-year cumulative revision rates showed a 5.7% revision rate for 263 patients receiving the...
Retrospective study results on patients undergoing sacroiliac (SI) joint fusion or fixation showed a 5.7% revision rate in fusion patients receiving SI-BONE’s iFuse™ vs. a 30.8% revision rate for those undergoing screw fixation.
Specifically, four-year cumulative revision rates showed a 5.7% revision rate for 263 patients receiving the triangular iFuse implant vs. a 30.8% revision rate for 36 patients who underwent SI joint screw fixation. At the longest follow-up, the cumulative probability of revision in the screw group was 79.8%. Subgroup analysis showed no predictors of revision other than device used (iFuse vs. screw).
Copy to clipboard 
